International Journal of Pharma Insight Studies

About the Journal 

The International Journal of Pharma Insight Studies (IJPIS) is a global, peer-reviewed academic journal committed to the advancement of pharmaceutical sciences. The journal provides a high-quality platform for researchers, academicians, clinicians, and industry professionals to publish innovative research, clinical findings, and technological developments. IJPIS follows an open-access model to ensure unrestricted dissemination of scientific knowledge worldwide.

Open Access Policy

The International Journal of Pharma Insight Studies (IJPIS) is a fully open-access journal. All published content is freely available to readers without any subscription or access charges.

In accordance with the Budapest Open Access Initiative (BOAI), users are permitted to read, download, copy, distribute, print, search, link, and use the full texts of articles for any lawful purpose without prior permission from the publisher or authors.

Open Access License

To guarantee full open-access availability, all articles published in IJPIS are licensed under the Creative Commons Attribution License 4.0 (CC BY 4.0).

1. Share: Copy and redistribute the material in any medium or format
2. Adapt: Remix, transform, and build upon the material for any purpose, including commercial use
3. Copyright: Authors retain full copyright and unrestricted publishing rights

Aims & Scope

IJPIS invites original research articles and review papers in the following core areas:

1. Pharmacology & Toxicology
2. Pharmaceutical Technology & Nanotechnology
3. Clinical & Hospital Pharmacy
4. Medicinal Chemistry & Biopharmaceutics
5. Pharmacogenomics & Drug Safety

Review Process and Publication Ethics – COPE, ICMJE & WAME Compliance

The International Journal of Pharma Insight Studies (IJPIS) strictly adheres to internationally recognized ethical standards prescribed by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME) to ensure integrity, transparency, accountability, and ethical responsibility in pharmaceutical and biomedical scholarly publishing.

1. COPE Ethical Guidelines

IJPIS follows COPE principles to uphold ethical publishing practices, address research misconduct, manage plagiarism and retractions, and maintain high editorial and peer-review standards.

2. ICMJE Author & Publication Standards

The journal complies with ICMJE recommendations to promote responsible authorship, ethical research conduct, conflict-of-interest disclosure, and accurate, transparent reporting of research findings.

3. WAME Ethical Editorial Principles

IJPIS aligns with WAME guidelines to ensure fairness, confidentiality, independence, and transparency in editorial decision-making and peer-review processes.

1. Plagiarism Policy: All submitted manuscripts undergo strict originality checks using Turnitin and iThenticate to ensure authenticity.
2. Peer Review: A Double-Blind Peer Review system is implemented to ensure unbiased and fair evaluation.
3. Editor & Author Responsibilities: Full transparency in authorship and mandatory disclosure of conflicts of interest are required.

For detailed policies, please visit the Publication Ethics and Malpractice Statement page.

Plagiarism Policy

International Journal of Pharma Insight Studies (IJPIS) maintains a strict zero-tolerance policy towards plagiarism. To ensure the highest standards of research integrity, every manuscript submitted to our journal undergoes a mandatory screening process:

1. Standard Screening: All submissions are rigorously checked for originality using Turnitin and iThenticate software.
2. Similarity Limit: We accept manuscripts with a similarity index of less than 15%. Any manuscript exceeding this limit is rejected or returned for revision.
3. Ethical Standards: We strictly prohibit direct copying, self-plagiarism, and improper paraphrasing.
4. Mandatory Requirement: Authors must ensure that all sources are accurately cited. Any violation of these ethical guidelines will lead to the immediate rejection of the manuscript.

Author & Editor Responsibilities

1. Clear authorship criteria and contributor transparency
2. Mandatory disclosure of conflicts of interest
3. Ethical handling of research data and citations
4. Editorial independence and accountability

Indexing & Visibility 

IJPIS is dedicated to maximizing the visibility and impact of published research and is currently indexed/tracked by:

1. Google Scholar: Global discoverability and citation tracking
2. Crossref (DOI): Unique Digital Object Identifier assigned to every published article

Why Choose IJPIS?

• Creative Commons Licensing: Authors retain copyright under CC BY 4.0
• Global Editorial Board: Guided by international pharmaceutical experts
• Rapid & Transparent Review Process

Latest Updates & Call for Papers

1. Now Accepting Submissions: Volume 2, Issue 6 (November–December 2025) – Published
2. Submission Deadline: 15 January 2026
3. Expected Publication Date: 28 February 2026

Submission

Authors may submit their manuscripts via email at [email protected] or through the online submission system: [Submit Manuscript]